Sangamo Therapeutics
SGMO
#10512
Rank
A$30.01 M
Marketcap
A$0.07244
Share price
0.00%
Change (1 day)
-91.24%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total assets

Total assets on the balance sheet as of September 2025 : A$0.12 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total assets are A$0.12 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sangamo Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$0.16 B-32.66%
2023-12-31A$0.24 B-70.64%
2022-12-31A$0.82 B-16.99%
2021-12-31A$0.99 B-18.42%
2020-12-31A$1.22 B34.05%
2019-12-31A$0.91 B8.65%
2018-12-31A$0.83 B128.18%
2017-12-31A$0.36 B67.68%
2016-12-31A$0.21 B-26.54%
2015-12-31A$0.29 B0.34%
2014-12-31A$0.29 B88.22%
2013-12-31A$0.15 B98.81%
2012-12-31A$79.41 M-6.76%
2011-12-31A$85.17 M37.34%
2010-12-31A$62.02 M-36.28%
2009-12-31A$97.33 M1.21%
2008-12-31A$96.17 M0.21%
2007-12-31A$95.96 M35.62%
2006-12-31A$70.75 M5.7%
2005-12-31A$66.94 M49.19%
2004-12-31A$44.87 M-27.85%
2003-12-31A$62.19 M-37.68%
2002-12-31A$99.79 M-40.09%
2001-12-31A$0.16 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$291.07 B 226,532.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$134.02 B 104,255.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$42.71 B 33,160.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
A$86.61 B 67,339.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$81.54 B 63,388.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$186.45 B 145,072.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$7.43 B 5,686.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$12.44 B 9,591.71%๐Ÿ‡บ๐Ÿ‡ธ USA